BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Retina
,
Early pregnancy factor
,
Doxorubicin
,
rs2300478
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptors activin
Summary
General Info
Curated Studies
Most Correlated Studies
Quadriceps expression profiles in MNST nulls and in WT treated with a soluble ActIIB receptor
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model.
Ionizing Radiation Alters Human Embryonic Stem Cell Properties and Differentiation Capacity by Dimin…
RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic …
Goat activin receptor type IIB knockdown by muscle specific promoter driven artificial microRNAs.
The therapeutic potential of soluble activin type IIB receptor treatment in a limb girdle muscular d…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Be…
Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peri…
Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, i…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ